| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |